Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Anemia in HIV-infected patients is a common clinical manifestation. We report on a 31-year-old Thai male, who had been HIV positive for 6 years, did not harbor any opportunistic infection, and had been receiving Highly Active Anti Retroviral Therapy (HAART) for one month, and who developed severe anemia. Investigation revealed pure red cell aplasia, suspected secondary to parvovirus B19 infection. This diagnosis was confirmed by the detection of parvovirus B19 DNA in his serum. He received blood transfusions for supportive treatment and continued on HAART to improve his immune status and to resolve the anemia. This case suggests that parvovirus B19 infection should be considered as a possible cause of anemia in HIV-infected individuals.


Journal article


The Southeast Asian journal of tropical medicine and public health

Publication Date





1216 - 1220


Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.


Humans, Parvovirus B19, Human, AIDS-Related Opportunistic Infections, Parvoviridae Infections, Red-Cell Aplasia, Pure, DNA, Viral, DNA Primers, Antiretroviral Therapy, Highly Active, Polymerase Chain Reaction, Base Sequence, Adult, Thailand, Male